Survivorship as an element of clinical trials in ovarian cancer.
作者信息
McAlpine Jessica N, Wenzel Lari B
机构信息
Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, University of British Columbia, Vancouver, Canada.
出版信息
Int J Gynecol Cancer. 2011 May;21(4):788-92. doi: 10.1097/IGC.0b013e31821bb717.
Abstract
摘要
相似文献
1
Survivorship as an element of clinical trials in ovarian cancer.卵巢癌临床试验中的生存情况作为一个要素
Int J Gynecol Cancer. 2011 May;21(4):788-92. doi: 10.1097/IGC.0b013e31821bb717.
2
[Current aspects of diagnosis, therapy and follow-up care of ovarian carcinoma].[卵巢癌诊断、治疗及随访的现状]
Z Arztl Fortbild (Jena). 1991 Mar 25;85(6):242-5.
3
Patient-reported outcomes: clinical trials in ovarian cancer.患者报告的结局：卵巢癌临床试验
Int J Gynecol Cancer. 2011 May;21(4):782-7. doi: 10.1097/IGC.0b013e31821bb8be.
4
Clinical trials and treatment of the elderly diagnosed with ovarian cancer.老年卵巢癌的临床试验和治疗。
Int J Gynecol Cancer. 2011 May;21(4):776-81. doi: 10.1097/IGC.0b013e31821bb700.
5
[Ovarian carcinoma].
Fortschr Geburtshilfe Gynakol. 1974;53:1-116.
6
[Diagnosis and treatment of epithelial cancer of the ovary. Apropos of 102 cases].[卵巢上皮癌的诊断与治疗。附102例报告]
Chirurgie. 1989;115(3):178-83; discussion 183-4.
7
[Technique and preliminary results in second-look laparoscopy in epithelial malignant ovarian tumors].[上皮性恶性卵巢肿瘤二次腹腔镜检查的技术及初步结果]
J Gynecol Obstet Biol Reprod (Paris). 1992;21(6):655-63.
8
Prognosis of 2,800 patients with epithelial ovarian cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital.1975年至1994年间在挪威镭医院确诊并接受治疗的2800例上皮性卵巢癌患者的预后情况。
Acta Obstet Gynecol Scand. 1998 Aug;77(7):777-81. doi: 10.1080/j.1600-0412.1998.770714.x.
9
Epithelial carcinoma of the ovary in the reproductive years: clinical and morphological characterization.育龄期卵巢上皮癌：临床及形态学特征
Gynecol Oncol. 1983 Jun;15(3):422-7. doi: 10.1016/0090-8258(83)90061-6.
10
The genetics, screening, and treatment of epithelial ovarian cancer: an update.上皮性卵巢癌的遗传学、筛查与治疗：最新进展
Cleve Clin J Med. 2000 Apr;67(4):294-8. doi: 10.3949/ccjm.67.4.294.
本文引用的文献
1
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.新辅助化疗与初始肿瘤细胞减灭术用于 IIIC 或 IV 期卵巢癌。
N Engl J Med. 2010 Sep 2;363(10):943-53. doi: 10.1056/NEJMoa0908806.
2
Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer.BRCA1 和 BRCA2 中的种系突变可能会增加卵巢癌中受益于聚（ADP 核糖）聚合酶抑制剂的患者数量。
J Clin Oncol. 2010 Aug 1;28(22):3570-6. doi: 10.1200/JCO.2009.27.2997. Epub 2010 Jul 6.
3
Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications.肿瘤类型和亚分期可预测Ⅰ期和Ⅱ期卵巢癌的生存率：见解与启示。
Gynecol Oncol. 2010 Jan;116(1):50-6. doi: 10.1016/j.ygyno.2009.09.029. Epub 2009 Oct 12.
4
The preclinical natural history of serous ovarian cancer: defining the target for early detection.浆液性卵巢癌的临床前自然史：确定早期检测的目标
PLoS Med. 2009 Jul;6(7):e1000114. doi: 10.1371/journal.pmed.1000114. Epub 2009 Jul 28.
5
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.手术模式的改变使晚期卵巢癌的无进展生存期和总生存期得到改善。
Gynecol Oncol. 2009 Jul;114(1):26-31. doi: 10.1016/j.ygyno.2009.03.018. Epub 2009 Apr 23.
6
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO).手术结果作为晚期上皮性卵巢癌预后因素的作用：三项前瞻性随机3期多中心试验的联合探索性分析：由妇科肿瘤学 Arbeitsgemeinschaft 卵巢癌研究小组（AGO-OVAR）和国家卵巢癌研究调查小组（GINECO）开展
Cancer. 2009 Mar 15;115(6):1234-44. doi: 10.1002/cncr.24149.
7
Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.卵巢癌亚型是不同的疾病：对生物标志物研究的启示。
PLoS Med. 2008 Dec 2;5(12):e232. doi: 10.1371/journal.pmed.0050232.
8
"BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations.卵巢癌中的“BRCA样”综合征：一项病例对照研究，描述与BRCA1和BRCA2突变相关的上皮性卵巢癌患者的临床特征和预后。
J Clin Oncol. 2008 Dec 1;26(34):5530-6. doi: 10.1200/JCO.2008.16.1703. Epub 2008 Oct 27.
9
Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.高危早期上皮性卵巢癌的预后因素：一项妇科肿瘤学组的研究
Cancer. 2008 May 15;112(10):2202-10. doi: 10.1002/cncr.23390.
10
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.肿瘤细胞减灭术后的肿瘤残留对IV期上皮性卵巢癌临床结局的预测：一项妇科肿瘤学组研究
J Clin Oncol. 2008 Jan 1;26(1):83-9. doi: 10.1200/JCO.2007.13.1953. Epub 2007 Nov 19.
Zotero 插件